Wei, Xiaoying
Chen, Lin
Yang, Zhonglin
Zeng, Daxiong
Tang, Dongjiang
Jiang, Junhong
Funding for this research was provided by:
Science and Technology Project of Suzhou Municipal Health Commission (LCZX202234)
Medical and Health Innovation Research Project of Suzhou Municipal Health Commission (CXYJ2024A07)
Article History
Received: 22 October 2025
Accepted: 18 January 2026
First Online: 31 January 2026
Declarations
:
: This study was approved by the Fourth Affiliated Hospital of Soochow University (Approval number 220154) and under a registered clinical trial number (ChiCTR2500096312: Prediction value of PD-L1 statue on circulating tumor cells to PD-1/PD-L1 immunotherapy of NSCLC). Written informed consent was obtained from all participants.
: Written informed consent for publication was obtained from the patient or their legal guardian.
: The authors declare no competing interests.